A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against lethal Nipah virus disease
Sign Up to like & getrecommendations! Published in 2022 at "Proceedings of the National Academy of Sciences of the United States of America"
DOI: 10.1073/pnas.2200065119
Abstract: Significance Concern has increased about the pandemic potential of Nipah virus (NiV). Similar to SARS-CoV-2, NiV is an RNA virus that is transmitted by respiratory droplets. There are currently no NiV vaccines licensed for human… read more here.
Keywords: vsv vectored; recombinant vsv; vectored vaccine; virus ... See more keywords
Measles-vectored vaccine approaches against viral infections: a focus on Chikungunya
Sign Up to like & getrecommendations! Published in 2019 at "Expert Review of Vaccines"
DOI: 10.1080/14760584.2019.1562908
Abstract: ABSTRACT Introduction: The large global burden of viral infections and especially the rapidly spreading vector-borne diseases and other emerging viral diseases show the need for new approaches in vaccine development. Several new vaccine technology platforms… read more here.
Keywords: measles vectored; vectored vaccine; viral infections; vaccine approaches ... See more keywords
Recombinant Bivalent Live Vectored Vaccine Against Classical Swine Fever and HP-PRRS Revealed Adequate Heterogeneous Protection Against NADC30-Like Strain
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Microbiology"
DOI: 10.3389/fmicb.2021.822749
Abstract: The recombinant bivalent live vectored vaccine rPRRSV-E2 has been proved to be a favorable genetic engineering vaccine against classical swine fever (CSF) and highly pathogenic porcine reproductive and respiratory syndrome (HP-PRRS). NADC30-like strains have recently… read more here.
Keywords: recombinant bivalent; bivalent live; strain; nadc30 like ... See more keywords
Assessment of an LSDV-Vectored Vaccine for Heterologous Prime-Boost Immunizations against HIV
Sign Up to like & getrecommendations! Published in 2021 at "Vaccines"
DOI: 10.3390/vaccines9111281
Abstract: The modest protective effects of the RV144 HIV-1 vaccine trial have prompted the further exploration of improved poxvirus vector systems that can yield better immune responses and protection. In this study, a recombinant lumpy skin… read more here.
Keywords: assessment lsdv; vectored vaccine; lsdv; vaccine heterologous ... See more keywords